Patent · US Active

Topical formulations, systems and methods

US9308181B2 · kind B2 · utility

12Cited by

9References

127Claims

0Family size

Assignee

Nuvo Research Inc. · CA

Inventors

Edward T. Kisak · San Diego, US
John M. Newsam · Village of La Jolla, US
Dominic King-Smith · San Diego, US
Pankaj Karande · Troy, US
Samir Mitragotri · Goleta, US
Tejas Desai · Mississauga, CA
Wade Hull · Kaysville, US

Key dates

Filing date	Mar 8, 2013
Grant date	Apr 12, 2016
Priority date	—
Expiry date	Apr 25, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61F2007/0261
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure is drawn to topical formulations, transdermal systems, and related methods. In one embodiment, a topical formulation is provided that includes a local anesthetic, a first compound, and a second compound. The first compound and second compound are different and each is selected from the group consisting of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate, and sodium lauryl sulfoacetate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.